Bandaram Pharma Packtech Ltd

Bandaram Pharma Packtech Board Meeting Date

Bandaram Pharma Packtech has scheduled a board meeting on 30.09.2026 to consider a proposal for a scheme of arrangement or amalgamation.

Bandaram Pharma Packtech Annual General Meeting

Bandaram Pharma Packtech Limited held its Annual General Meeting on September 24, 2026, approving financial statements and re-appointing auditors and directors.

Bandaram Pharma Packtech Annual General Meeting

Bandaram Pharma Packtech submitted its Annual Report and notice for the AGM, which is now rescheduled for September 24, 2026.

Bandaram Pharma Packtech Management Change

Bandaram Pharma Packtech re-appointed its statutory auditor for 36 months and an independent director for a 60-month term, both approved in the board meeting.

Bandaram Pharma Packtech Q1 FY27 Results: Net Profit ₹0.7 Cr, Up 600.0% QoQ

Bandaram Pharma Packtech Ltd reported revenue from operations of ₹24 Cr (+196.3% YoY) and net profit of ₹0.7 Cr for Q1 FY27.

Key figure

Net profit ₹0.7 Cr

Bandaram Pharma Packtech Board Meeting Date

Bandaram Pharma Packtech will hold a board meeting on August 13, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.

Bandaram Pharma Packtech Other Announcement

Bandaram Pharma Packtech Ltd submitted its quarterly shareholding pattern for the quarter ended June 30, 2026, in compliance with SEBI regulations.

Bandaram Pharma Packtech Price Movement Clarification

Bandaram Pharma Packtech clarifies no price-sensitive events caused recent share price rise. Company assures prompt disclosure if any future events occur.

Bandaram Pharma Packtech Bags ₹27.71 Cr Order

Bandaram Pharma Packtech's subsidiary received two work orders worth Rs.27.71 Crore from Government of Telangana. The orders for textbook printing and distribution are to be executed by August 2026.

Value

₹27.71 Cr

Execution

JUNE- AUGUST 2026

Bandaram Pharma Packtech Management Change

Mr. NSK Aakarsh Raj resigned as Whole-time Director of Bandaram Pharma Packtech Limited effective June 5, 2026. The departure was cited for personal and professional reasons.

Bandaram Pharma Packtech Q4 FY26 Results: Net Profit ₹0.1 Cr, Down 50.0% YoY

Bandaram Pharma Packtech Ltd reported revenue from operations of ₹26.3 Cr (+209.4% YoY) and net profit of ₹0.1 Cr (-50.0% YoY) for Q4 FY26.

Key figure

Net profit ₹0.1 Cr · -50.0% YoY

Bandaram Pharma Packtech Financial Results

Bandaram Pharma Packtech Limited reported audited financial results for the year ended March 31, 2026. The Board also appointed M/s. MGR & Co. as internal auditors.

Bandaram Pharma Packtech Bags ₹3.87 Cr Order

Bandaram Pharma Packtech's subsidiary secured a ₹3.87 Crore order from M/s S. A. Printers. The contract involves supplying textbook printing materials through August 2026.

Value

₹3.87 Cr

Execution

JUNE- AUGUST 2026

Bandaram Pharma Packtech Bags ₹5.87 Cr Order

Bandaram Pharma Packtech's subsidiary secured a ₹5.87 Crore order from Vijayaa Print Solutions. The contract for textbook material supply strengthens short-term revenue visibility.

Value

₹5.87 Cr

Execution

JUNE- AUGUST 2026

Bandaram Pharma Packtech Bags ₹37.44 Cr Order

Bandaram Pharma Packtech's subsidiary secured textbook printing orders worth ₹37.44 Crore from the Telangana government. The project will be executed between June and August 2026.

Value

₹37.44 Cr

Execution

JUNE- AUGUST 2026

Bandaram Pharma Packtech Board Meeting Date

Bandaram Pharma Packtech scheduled a board meeting for May 30, 2026. Directors will consider and approve audited financial results for the 2026 fiscal year.

Bandaram Pharma Packtech Debt & Borrowing

Bandaram Pharma Packtech Limited submitted its annual disclosure confirming it does not meet the criteria for 'Large Corporate' identification for FY 2025-26. Consequently, mandatory borrowing through debt securities is not applicable. This is a routine regulatory compliance filing under the SEBI Large Corporate framework.

Bandaram Pharma Packtech Debt & Borrowing

Bandaram Pharma Packtech Ltd informed BSE that it does not qualify as a 'Large Corporate' for FY 2026-27. The company reported outstanding borrowings of ₹3.48 Crore as of March 31, 2026, which is below the ₹1,000 Crore threshold required for the mandatory SEBI debt-borrowing framework.

Bandaram Pharma Packtech Q3 FY26 Results: Net Profit ₹0.3 Cr, Up 200.0% QoQ

Bandaram Pharma Packtech Ltd reported net profit of ₹0.3 Cr for Q3 FY26.

Key figure

Net profit ₹0.3 Cr

Bandaram Pharma Packtech Board Meeting Outcome

Bandaram Pharma Packtech's board approved material related party transactions with its subsidiary, VSR Paper and Packaging. An EGM is scheduled for April 27, 2026, to regularise Additional Director Mr. Eswar Reddy Putturu and seek shareholder approval for these transactions.